Efficacy and Safety of Baricitinb in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study in Pediatric Patients with Moderate-to-Severe Atopic Dermatitis

被引：0

作者：

Torrelo, A. ^{[1
]}

Rewerska, B. ^{[2
]}

Paller, Amy ^{[3
]}

Prakash, A. ^{[4
]}

Zhu, D. ^{[4
]}

Pontes, M. ^{[4
]}

Wu, Wen-Shuo ^{[4
]}

Eichenfield, Lawrence F. ^{[5
,6
]}

Boecker, Ulrike ^{[7
]}

机构：

[1] Hosp Infantil Univ San Jose, Bogota, Colombia

[2] Diamond Clin, Krakow, Poland

[3] Univ Northwestern Univ, Feinberg Sch Med, Chicago, IL USA

[4] Eli Lilly & Co, Indianapolis, IN 46285 USA

[5] Univ Calif San Diego, San Diego, CA 92103 USA

[6] Rady Childrens Hosp, San Diego, CA USA

[7] Lilly Deutschland GmbH, Bad Homburg, Germany

来源：

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2023年 / 21卷

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

P153

引用

页码：99 / 99

页数：1

共 50 条

[1] The efficacy and safety of dupilumab in Chinese patients with moderate-to-severe atopic dermatitis: a randomized, double-blind, placebo-controlled study
Zhao, Y.
Wu, L.
Lu, Q.
Gao, X.
Zhu, X.
Yao, X.
Li, L.
Li, W.
Ding, Y.
Song, Z.
Liu, L.
Dang, N.
Zhang, C.
Liu, X.
Gu, J.
Wang, J.
Geng, S.
Liu, Q.
Guo, Y.
Dong, L.
Su, H.
Bai, L.
O'Malley, J. T.
Luo, J.
Laws, E.
Mannent, L.
Ruddy, M.
Amin, N.
Bansal, A.
Ota, T.
Wang, M.
Zhang, J.
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : 633 - 641
[2] Efficacy and safety of dupilumab with concomitant topical corticosteroids in Japanese pediatric patients with moderate-to-severe atopic dermatitis: A randomized, double-blind, placebo-controlled phase 3 study
Ebisawa, Motohiro
Kataoka, Yoko
Tanaka, Akio
Nagao, Mizuho
Laws, Elizabeth
Mortensen, Eric
Nawata, Hisakatsu
Arima, Kazuhiko
Watanabe, Daisuke
Lu, Xin
Maloney, Jennifer
Dubost-Brama, Ariane
Bansal, Ashish
Yahata, Kenji
[J]. ALLERGOLOGY INTERNATIONAL, 2024, 73 (04) : 532 - 542
[3] Risankizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
Tyring, Stephen K. K.
Rich, Phoebe
Tada, Yayoi
Beeck, Stefan
Messina, Izabella
Liu, Jie
Huang, Xiaohong
Shumack, Stephen
[J]. DERMATOLOGY AND THERAPY, 2023, 13 (02) : 595 - 608
[4] Risankizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
Stephen K. Tyring
Phoebe Rich
Yayoi Tada
Stefan Beeck
Izabella Messina
Jie Liu
Xiaohong Huang
Stephen Shumack
[J]. Dermatology and Therapy, 2023, 13 : 595 - 608
[5] Efficacy and safety of ustekinumab in Japanese patients with severe atopic dermatitis: a randomized, double-blind, placebo-controlled, phase II study
Saeki, H.
Kabashima, K.
Tokura, Y.
Murata, Y.
Shiraishi, A.
Tamamura, R.
Randazzo, B.
Imanaka, K.
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2017, 177 (02) : 419 - 427
[6] EFFICACY AND SAFETY OF DUPILUMAB IN THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS IN CHINESE ADULTS: A MULTICENTER, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 TRIAL
Zhao, Yan
Wu, Liming
Lu, Qianjin
Gao, Xinghua
Zhu, Xiaohong
Yao, Xu
Li, Linfeng
Li, Wei
Ding, Yangfeng
Song, Zhiqiang
Liu, Lingling
Dang, Ningning
Zhang, Chunlei
Liu, Xiaoming
Gu, Jun
Wang, Jinyan
Geng, Songhai
Liu, Qunazhong
Guo, Yifeng
Lv, Dong
Ren, Gong
Yang, Xiumin
Deng, Danqi
Li, Shanshan
Han, Xiuping
Biao, Shuzhen
Zheng, Min
Dong, Li
Su, Huijuan
Bai, Lili
O'Malley, John T.
Luo, Junxiang
Zhang, Jianzhong
[J]. ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 58 - 58
[7] Efficacy and safety of CM310 in moderate-to-severe atopic dermatitis: A multicenter, randomized, double-blind, placebo-controlled phase 2b trial
Zhao, Yan
Zhang, Jianzhong
Yang, Bin
Li, Jingyi
Ding, Yangfeng
Wu, Liming
Zhang, Litao
Wang, Jinyan
Zhu, Xiaohong
Zhang, Furen
Tao, Xiaohua
Li, Yumei
Zhang, Chunlei
Li, Linfeng
Lu, Jianyun
Diao, Qingchun
Lu, Qianjin
Man, Xiaoyong
Li, Fuqiu
Xia, Xiujuan
Cheng, Hao
Jia, Yingmin
Zhao, Guoqing
Yan, Jinchun
Chen, Bo
[J]. CHINESE MEDICAL JOURNAL, 2024, 137 (02) : 200 - 208
[8] Efficacy and safety of CM310 in moderate-to-severe atopic dermatitis: A multicenter, randomized, double-blind, placebo-controlled phase 2b trial
Zhao Yan
Zhang Jianzhong
Yang Bin
Li Jingyi
Ding Yangfeng
Wu Liming
Zhang Litao
Wang Jinyan
Zhu Xiaohong
Zhang Furen
Tao Xiaohua
Li Yumei
Zhang Chunlei
Li Linfeng
Lu Jianyun
Diao Qingchun
Lu Qianjin
Man Xiaoyong
Li Fuqiu
Xia Xiujuan
Cheng Hao
Jia Yingmin
Zhao Guoqing
Yan Jinchun
Chen Bo
[J]. 中华医学杂志(英文版), 2024, 137 (02)
[9] A phase 2b, randomized, double-blind, placebo-controlled, global study to evaluate the efficacy and safety of ANB032 in the treatment of moderate-to-severe atopic dermatitis
Ehst, B.
Silverberg, J.
Lizzul, P.
Luu, K.
Papacharalambous, J.
Raina, P.
Randazzo, B.
Sibley, C.
Guttman-Yassky, E.
[J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (11) : S347 - S347
[10] Safety of tralokinumab in adult patients with moderate-to-severe atopic dermatitis: pooled analysis of five randomized, double-blind, placebo-controlled phase II and phase III trials
Simpson, Eric L.
Merola, Joseph F.
Silverberg, Jonathan, I
Reich, Kristian
Warren, Richard B.
Staumont-Salle, Delphine
Girolomoni, Giampiero
Papp, Kim
de Bruin-Weller, Marjolein
Thyssen, Jacob P.
Zachariae, Rebecca
Olsen, Christiana K.
Wollenberg, Andreas
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (06) : 888 - 899

← 1 2 3 4 5 →